Russell Frank Company’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $56K | Hold |
995
| – | – | ﹤0.01% | 2854 |
|
|
2015
Q4 | $241K | Hold |
995
| – | – | ﹤0.01% | 2661 |
|
|
2015
Q3 | $157K | Sell |
995
-498
| -33% | -$78.6K | ﹤0.01% | 2749 |
|
|
2015
Q2 | $564K | Buy |
1,493
+995
| +200% | +$376K | ﹤0.01% | 2541 |
|
|
2015
Q1 | $208K | Sell |
498
-2,597
| -84% | -$1.08M | ﹤0.01% | 2638 |
|
|
2014
Q4 | $844K | Buy |
3,095
+2,597
| +521% | +$708K | ﹤0.01% | 2227 |
|
|
2014
Q3 | $97K | Sell |
498
-932
| -65% | -$182K | ﹤0.01% | 2666 |
|
|
2014
Q2 | $282K | Sell |
1,430
-794
| -36% | -$157K | ﹤0.01% | 2476 |
|
|
2014
Q1 | $487K | Sell |
2,224
-11,392
| -84% | -$2.49M | ﹤0.01% | 2395 |
|
|
2013
Q4 | $5.3M | Buy |
13,616
+2,823
| +26% | +$1.1M | 0.01% | 1199 |
|
|
2013
Q3 | $5.74M | Sell |
10,793
-4,486
| -29% | -$2.38M | 0.01% | 1245 |
|
|
2013
Q2 | $3.58M | Buy |
+15,279
| New | +$3.58M | 0.01% | 1440 |
|